Early hypertension and neutropenia are predictors of treatment efficacy in metastatic colorectal cancer patients administered FOLFIRI and vascular endothelial growth factor inhibitors as second ‐line chemotherapy

ConclusionsChemotherapeutic efficacy did not differ between the groups. Grade 3 or 4 AEs within the first four cycles of treatment and prior BEV exposure may be an effective predictor of treatment efficacy in mCRC patients administered VEGF inhibitors as second ‐line chemotherapy.

https://onlinelibrary.wiley.com/doi/abs/10.1002/cam4.3638?af=R

Source: Cancer Medicine - December 21, 2020 Category: Cancer & Oncology Authors: Hiroki Osumi, Eiji Shinozaki, Akira Ooki, Takeru Wakatsuki, Daisaku Kamiimabeppu, Taro Sato, Izuma Nakayama, Mariko Ogura, Daisuke Takahari, Keisho Chin, Kensei Yamaguchi Tags: ORIGINAL RESEARCH Source Type: research